PDSB
Price
$0.76
Change
-$0.00 (-0.00%)
Updated
Nov 21 closing price
Capitalization
41.34M
123 days until earnings call
Intraday BUY SELL Signals
VERA
Price
$28.46
Change
+$0.59 (+2.12%)
Updated
Nov 21 closing price
Capitalization
1.82B
116 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

PDSB vs VERA

Header iconPDSB vs VERA Comparison
Open Charts PDSB vs VERABanner chart's image
PDS Biotechnology
Price$0.76
Change-$0.00 (-0.00%)
Volume$423.06K
Capitalization41.34M
Vera Therapeutics
Price$28.46
Change+$0.59 (+2.12%)
Volume$789.28K
Capitalization1.82B
PDSB vs VERA Comparison Chart in %
PDSB
Daily Signal:
Gain/Loss:
VERA
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
PDSB vs. VERA commentary
Nov 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PDSB is a Hold and VERA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 23, 2025
Stock price -- (PDSB: $0.76 vs. VERA: $28.46)
Brand notoriety: PDSB and VERA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PDSB: 49% vs. VERA: 54%
Market capitalization -- PDSB: $41.34M vs. VERA: $1.82B
PDSB [@Biotechnology] is valued at $41.34M. VERA’s [@Biotechnology] market capitalization is $1.82B. The market cap for tickers in the [@Biotechnology] industry ranges from $108.28B to $0. The average market capitalization across the [@Biotechnology] industry is $2.13B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PDSB’s FA Score shows that 1 FA rating(s) are green whileVERA’s FA Score has 0 green FA rating(s).

  • PDSB’s FA Score: 1 green, 4 red.
  • VERA’s FA Score: 0 green, 5 red.
According to our system of comparison, VERA is a better buy in the long-term than PDSB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PDSB’s TA Score shows that 3 TA indicator(s) are bullish while VERA’s TA Score has 8 bullish TA indicator(s).

  • PDSB’s TA Score: 3 bullish, 5 bearish.
  • VERA’s TA Score: 8 bullish, 3 bearish.
According to our system of comparison, VERA is a better buy in the short-term than PDSB.

Price Growth

PDSB (@Biotechnology) experienced а -10.12% price change this week, while VERA (@Biotechnology) price change was +0.39% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.01%. For the same industry, the average monthly price growth was -3.31%, and the average quarterly price growth was +62.87%.

Reported Earning Dates

PDSB is expected to report earnings on Mar 26, 2026.

VERA is expected to report earnings on Mar 19, 2026.

Industries' Descriptions

@Biotechnology (-1.01% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VERA($1.82B) has a higher market cap than PDSB($41.3M). VERA YTD gains are higher at: -32.703 vs. PDSB (-53.656). PDSB has higher annual earnings (EBITDA): -32.36M vs. VERA (-210.52M). VERA has more cash in the bank: 557M vs. PDSB (31.9M). PDSB has less debt than VERA: PDSB (18.5M) vs VERA (77.6M). PDSB (0) and VERA (0) have equivalent revenues.
PDSBVERAPDSB / VERA
Capitalization41.3M1.82B2%
EBITDA-32.36M-210.52M15%
Gain YTD-53.656-32.703164%
P/E RatioN/AN/A-
Revenue00-
Total Cash31.9M557M6%
Total Debt18.5M77.6M24%
FUNDAMENTALS RATINGS
PDSB: Fundamental Ratings
PDSB
OUTLOOK RATING
1..100
90
VALUATION
overvalued / fair valued / undervalued
1..100
32
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
91
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
PDSBVERA
RSI
ODDS (%)
N/A
Bullish Trend 3 days ago
77%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
81%
Bearish Trend 3 days ago
86%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
84%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
79%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
89%
Bullish Trend 3 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
83%
Advances
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 12 days ago
86%
Declines
ODDS (%)
Bearish Trend 7 days ago
89%
Bearish Trend 4 days ago
82%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 3 days ago
80%
Aroon
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 3 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
PDSB
Daily Signal:
Gain/Loss:
VERA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GCPYX21.520.17
+0.80%
Gateway Equity Call Premium Y
QMGYX13.360.08
+0.60%
Invesco Advantage International Y
TRNEX42.430.24
+0.57%
T. Rowe Price New Era I
MLACX4.730.02
+0.42%
NYLI Winslow Large Cap Growth Class C
GTORX41.010.14
+0.34%
Goldman Sachs Technology Opps R6

PDSB and

Correlation & Price change

A.I.dvisor indicates that over the last year, PDSB has been loosely correlated with RGNX. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if PDSB jumps, then RGNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PDSB
1D Price
Change %
PDSB100%
-0.09%
RGNX - PDSB
46%
Loosely correlated
+8.56%
RXRX - PDSB
43%
Loosely correlated
+8.31%
AXON - PDSB
43%
Loosely correlated
+0.46%
KYMR - PDSB
42%
Loosely correlated
+2.18%
DYN - PDSB
42%
Loosely correlated
+5.27%
More